LFST Stock Recent News

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims LifeStance Health Group, Inc. (NASDAQ: LFST) and Customers Bancorp, Inc. (NYSE:CUBI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to report that it has completed, pursuant to a share purchase agreement entered into on August 16, 2024 with an arm's length party, the acquisition of the shares of 1000594871 Ontario Corp. (“4871”) which holds key intellectual property resulting from a patent application and all rights thereto.

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc.(TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, In response to inquiries from many of you, we wish to set forth the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. (“CannMart”) via a sale to Simply Solventless Concentrates Ltd. (“SSC”) under the terms of the agreement set forth in our press release of June 25, 2024.

The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jack Senft - William Blair Dylan Finley - UBS Jack Slevin - Jefferies Stephanie Davis - Barclays Operator Thank you for standing by. My name is Jermanie, and I will be your conference operator today.

LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago.

SCOTTSDALE, Ariz., Aug. 08, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2024.

NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.

NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.

NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.